The updated content includes instructions on interpreting blood test results and dosing with Felimazole (thiamazole), which is now available as both a tablet and a honey-flavoured oral solution.
The new Felimazole Oral Solution formulation is presented in a syringe graduated in 0.25 mg increments to ensure accurate dosing.
Thomas Johnson, Dechra companion animal brand manager said: “Consistent management and accurate treatment is key to enabling cats with feline hyperthyroidism to lead long and healthy lives.”
Dechra’s Endocrine app already covers Addison’s disease and canine Cushing’s syndrome. The inclusion of feline hyperthyroidism content aims to provide a single resource for veterinarians managing endocrine disorders in companion animals.
Dechra’s Endocrine app is available at the Apple App Store or Google Play Store
https://www.dechra.co.uk/products#/search=Felimazole
PS: Whilst you're here, take a moment to see our latest job opportunities for vets.